XPA A23G polymorphism is associated with the elevated response to platinum-based chemotherapy in advanced non-small cell lung cancer

Acta Biochimica et Biophysica Sinica

Volumn 41, Issue 5, 2009, Pages 429-435

  Feng, Jifeng ^a,b   Sun, Xinchen ^a   Sun, Ning ^a   Qin, Shukui ^c   Li, Fan ^a   Cheng, Hongyan ^a   Chen, Baoan ^a   Cao, Yuandong ^a   Ma, Jun ^a   Cheng, Lu ^a   Lu, Zuhong ^a   Ji, Jiazhong ^d   Zhou, Yingfeng ^d  

^a SOUTHEAST UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

^c The 81th Hospital of People's Liberation Army   (China)

^d Jiangbei People Hospital   (China)

Author keywords

Chemotherapy; Genechip; Non small cell lung cancer; Nucleotide excision repair; Single nucleotide polymorphism; XPA; XPG

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; DEOXYCYTIDINE; DNA BINDING PROTEIN; DNA EXCISION REPAIR PROTEIN ERCC 5; DNA EXCISION REPAIR PROTEIN ERCC-5; DOCETAXEL; DRUG DERIVATIVE; ENDONUCLEASE; GEMCITABINE; NAVELBINE; NUCLEAR PROTEIN; PACLITAXEL; TAXOID; TRANSCRIPTION FACTOR; VINBLASTINE; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XPA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; FEMALE; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PACLITAXEL; POLYMORPHISM, SINGLE NUCLEOTIDE; TAXOIDS; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; VINBLASTINE; XERODERMA PIGMENTOSUM GROUP A PROTEIN;

EID: 66449119340     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmp027     Document Type: Article

References (30)

1. Guilbert JJ. The world health report 2002-reducing risks, promoting healthy life. Educ Health (Abingdon) 2003, 16: 230. (Pubitemid 36939565)
2. Spiro SG and Silvestri GA. The treatment of advanced non-small cell lung cancer. Curr Opin Pulm Med 2005, 11: 287-291. (Pubitemid 41073150)
3. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J and Zhu J, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. New Engl J Med 2002, 346: 92-98. (Pubitemid 34438899)
4. Viktorsson K, De Petris L and Lewensohn R. The role of p53 in treatment responses of lung cancer. Biochem Biophys Res Commun 2005, 331: 868-880. (Pubitemid 40615518)
5. Yamamoto K, Yamamoto M, Hanada K, Nogi Y, Matsuyama T and Muramatsu M. Multiple protein-protein interactions by RNA polymer- ase I-associated factor PAF49 and role of PAF49 in rRNA transcription. Mol Cell Biol 2004, 24: 6338-6349. (Pubitemid 38891134)
6. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K and Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004, 73: 39-85. (Pubitemid 39050363)
7. Reed E. Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy. Cancer Treat Rev 1998, 24: 331-344. (Pubitemid 28537769)
8. Yokoi M, Masutani C, Maekawa T, Sugasawa K, Ohkuma Y and Hanaoka F. The xeroderma pigmentosum group C protein complex XPC-HR23B plays an important role in recruitment of transcription factor IIH to damaged DNA. J Biol Chem 2000, 257: 9870-9875. (Pubitemid 30185224)
9. You JS, Wang M and Lee SH. Biochemical analysis of the damage recognition process in nucleotide excision repair. J Biol Chem 2003, 278: 7476-7485. (Pubitemid 36800754)
10. Volker M, Mone MJ, Karmakar P, van Hoffen A, Schul W, Vermeulen W and Hoeijmakers JH, et al. Sequential assembly of the nucleotide excision repair factors in vivo. Mol Cell 2001, 8: 213-224. (Pubitemid 32772919)
11. O'Donovan A, Davies AA, Moggs JG, West SC and Wood RD. XPG endonuclease makes the 3' incision in human DNA nucleotide excision repair. Nature 1994, 371: 432-435. (Pubitemid 24302560)
12. Biggerstaff M, Szymkowski DE and Wood RD. Co-correction of the ERCC1, ERCC4 and xeroderma pigmentosum group F DNA repair defects in vitro. EMBO J 1993, 12: 3685-3692. (Pubitemid 23256456)
13. van Vuuren AJ, Appeldoorn E, Odijk H, Yasui A, Jaspers NG, Bootsma D and Hoeijmakers JH, Evidence for a repair enzyme complex involving ERCC1 and complementing activities of ERCC4, ERCC11 and xeroderma pigmentosum group F. EMBO J 1993, 12: 3693-3701. (Pubitemid 23256457)
14. Bernig T and Chanock SJ. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer. Expert Rev Mol Diagn 2006, 6: 319-331. (Pubitemid 44174338)
15. Miller AB, Hoogstraten B, Staquet M and Winkler A. Reporting results of cancer treatment. Cancer 1981, 47: 207-214. (Pubitemid 11167383)
16. Xiao PF, Cheng L, Wan Y, Sun BL, Chen ZZ, Zhang SY and Zhang CZ, et al. An improved gel-based DNA microarray method for detecting single nucleotide mismatch. Electrophoresis 2006, 27: 3904-3915. (Pubitemid 44608410)
17. Xiao P, Huang H, Zhou G and Lu Z. Gel immobilization of acrylamide-modified single-stranded DNA template for pyrosequencing. Electrophoresis 2007, 28: 1903-1912. (Pubitemid 47040394)
18. Masters JR and Koberle B. Curing metastatic cancer: lessons from testi- cular germ-cell tumours. Nat Rev Cancer 2003, 3: 517-525. (Pubitemid 37328839)
19. Wu XM, Fan W, Xu SQ and Zhou Y. Sensitization to the cytotoxicity of cisplatin by transfection with nucleotide excision repair gene xero- derma pigmentosun group A antisense RNA in human lung adenocarci-noma cells. Clin Cancer Res 2003, 9: 5874-5879. (Pubitemid 38018070)
20. Butkiewicz D, Rusin M, Harris CC and Chorazy M. Identification of four single nucleotide polymorphisms in DNA repair genes: XPA and XPB (ERCC3) in Polish population. Hum Mutat 2000, 15: 577-578.
21. Park JY, Park SH, Choi JE, Lee SY, Jeon HS, Cha SI and Kim CH, et al. Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2002, 11: 993-997. (Pubitemid 35192648)
22. Sun X, Xu R, Deng Y, Cheng H, Ma J, Ji J and Zhou Y. Effects of tet- randrine on apoptosis and radiosensitivity of nasopharyngeal carcinoma cell line CNE. Acta Biochim Biophys Sin 2007, 39: 869-878. (Pubitemid 350136894)
23. Kozak M. Role of ATP in binding and migration of 40S ribosomal sub-units. Cell 1990, 22: 459-467.
24. Tanaka K, Miura N, Satokata I, Miyamoto I, Yoshida MC, Satoh Y and Kondo S, et al. Analysis of a human DNA excision repair gene involved in group A Xeroderma pigmentosum and containing a zinc-finger domain. Nature 1990, 348: 73-76. (Pubitemid 20387512)
25. Friedberg EC. How nucleotide excision repair protects against cancer.Nat Rev Cancer 2001, 1: 22-33. (Pubitemid 33741878)
26. de Laat WL, Appeldoorn E, Sugasawa K, Weterings E, Jaspers NG and Hoeijmakers JH. DNA-binding polarity of human replication protein A positions nucleases in nucleotide excision repair. Genes Dev 1998, 12: 2598-2609. (Pubitemid 28406961)
27. Jeon HS, Kim KM, Park SH, Lee SY, Choi JE, Lee GY and Kam S, et al. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. Carcinogenesis 2003, 24: 1677-1681. (Pubitemid 37304674)
28. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L and Phillips DH, et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006, 27: 560-567. (Pubitemid 43372885)
29. Vila JM, Moreno I, Monzo M, Ibeas R, Moreno J, Pinuaga M and Martinez F, et al. XPD, XPA, ERCC1 and XPG/ERCC5 single nucleo- tide polymorphisms (SNPs) in oxaliplatin-treated colorectal cancer (CRC). J Clin Oncol 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition) 2004, 22: 3677.
30. Takebayashi Y, Pourquier P, Zimonjic DB, Nakayama K, Emmert S, Ueda T and Urasaki Y, et al. Antiproliferative activity of ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair. Nat Med 2001, 7: 961-966. (Pubitemid 32756435)